The molecular mechanisms underlying cardiac hypertrophy and heart failure have been extensively studied, and many pathways involved in these processes have been uncovered, such as thyroid hormone, IGF1/Akt, calcineurin/NFAT and TGF-β/Smad-signaling pathways. Here, IGF1 is linked to cardiac hypertrophy.